Some time ago, Prolepha introduced amisulpride tablets (brand name Aktiprol®) in the strengths of 50 mg, 100 mg, 200 mg, and 400 mg to the Dutch market. Amisulpride is an antipsychotic, indicated for use in schizophrenia. Amisulpride was initially only available in the Netherlands as a compassionate-use supply (collegial delivery) and as an imported preparation; Prolepha currently offers the first and only registered alternative. We are pleased to announce that amisulpride will be included in the GVS (Drug Reimbursement System) as of December 1st next. As of December 1st, our product will therefore be fully reimbursed for the Dutch patient population.
Deel dit bericht